期刊文献+

几种QSAR建模方法的研究进展与应用 被引量:3

Research Progress and Application in the Several QSAR Modeling Method
下载PDF
导出
摘要 定量构效关系(QSAR)对药物设计和新药研制、环境毒物的毒性评价与预测有着显著的作用,本文简单介绍了几种QSAR建模方法:多元线性回归(MLR)、主成分分析(PCA)、偏最小二乘法(PLS)、人工神经网络(ANN)和支持向量机(SVM),并对这几种不同的建模方法在实际中的应用进行举例。可以看出PLS和ANNS是优秀的建模方法,预测能力强,SVM通过结构风险最小化原则建模,有效将期望风险降至最低,模型预测力得到显著提高,在环境毒物评价中具有广阔的应用前景。 Quantitative structure - activity relationship of the design and :levelopment of new drugs, toxicity evaluation and prediction of toxic environment plays a role. This paper briefly described several QSAR modeling methods : multiple linear regression, principal component analysis, partial least squares, artificial neural network and support vector machine, and that several different modeling methods for the application in practice. It showed that the PLS and ANN were excellent modeling methods, predictive capability was very good, SVM modeling through structural risk minimization principle, to effectively minimized the risks expectations that the model prediction had improved significantly, and the environmental toxicology evaluation and prediction had broad application prospects.
出处 《农业环境科学学报》 CAS CSCD 北大核心 2007年第B10期651-655,共5页 Journal of Agro-Environment Science
关键词 定量构效关系 多元线性回归 偏最小二乘法 支持向量机 人工神经网络 quantitative structure activity relationship multiple linear regression partial least squares support vector machines artificial neural networks
  • 相关文献

参考文献21

二级参考文献207

共引文献294

同被引文献39

  • 1陈凝木子,黄齐茂,郭嘉,池汝安,吴元欣,巨修练.黄酮类化合物的3D-QSAR研究[J].计算机与应用化学,2009,26(2):183-187. 被引量:6
  • 2姜晓华,龙亚秋.结构多样的HIV-1整合酶抑制剂:过去、现在和未来[J].有机化学,2004,24(11):1380-1388. 被引量:7
  • 3梅虎,梁桂兆,周原,李志良.支持向量机用于定量构效关系建模的研究[J].科学通报,2005,50(16):1703-1708. 被引量:28
  • 4郭亦然,张燕玲,乔延江.氯代芳烃类化合物毒性及三维结构的定量关系研究[J].中国实验方剂学杂志,2006,12(7):63-66. 被引量:4
  • 5刘娟芳,曾丹苓,蔡智勇,高虹.扩散系数的分子动力学模拟[J].工程热物理学报,2006,27(3):373-375. 被引量:11
  • 6POMMIER Y, JOHNSON A A, MARCHAND C. lntegrase inhibitors to treat H1V/AIDS [ J ]. Nat Rev Drug Discov, 2005, 4(3): 236-248.
  • 7DAYAM R, SANCHEZ T, CLEMENT O, et al. β-Diketo acid pharmacophore hypothesis: 1. discovery of a novel class of H1V -1 integrase inhibitors [ J ]. J Med Chem, 2005, 48(1): 111-120.
  • 8HAZUDA D J, PETER F, MARC W, et al. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replicatoion in cells [ J ]. Science, 2000, 287 (5453) : 646-650.
  • 9EGBERTSONM S. H1V integrase inhibitors: from diketoacids to heterocyclic templates: a history of HIV integrase medicinal chemistry at merck west point and merck rome (IRBM) [J]. Current Topics in Medicinal Chemistry, 2007, 7(13): 1251-1272.
  • 10STEIGBIGEL R, KUMARP, ERON J, et al. Results of BENCHMRK-2, a phase m study evaluating the efficacy and safety of MK-0518, a novel HIV- 1 integrase inhibitor, in patients with triple-class resistant virus[ C ]// 14th Conference on Retroviruses and Opportunistie Infections, Los Angeles, February 25-28, 2007.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部